Evidence map›Paper›PMID 39250626›Full record

ArticleIndian journal of pharmacology2024

Advancing pediatric drug development in South Asia: Current landscape and vision for the future.

Rajesh Krishna, Manoj Jadhav, Rama Sivasubramanian, Gangadhar Sunkara, Vikram Gota, Vis Niranjan, Vipin Dhote, Nidhi Sapkal, Nirmala N Rege, Samir Sethi and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rajesh KrishnaDrug Development Solutions, Certara USA, Inc., Princeton, Hillsborough, USA.
Manoj JadhavClinical Development, ISHA Therapeutics, Hillsborough, USA.
Rama SivasubramanianClinical Development, Novartis Healthcare Pvt. Ltd, Hyderabad, India.
Gangadhar SunkaraDevelopment, Novartis Pharmaceuticals, East Hanover, USA.
Vikram GotaClinial Pharmacology, Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India.
Vis NiranjanTranslational Medicine, RxMD, Chennai, India.
Vipin DhotePharmacology, Vidya Niketan Samiti Faculty of Pharmacy, Bhopal, India.
Nidhi SapkalPharmaceutics, Guru Nanak College of Pharmacy, Nagpur, India.
Nirmala N RegePharmacology, Seth GS Medical college and KEM Hospital, Mumbai, India.
Samir SethiAdvocacy, Indian Rett Syndrome Foundation, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Bikash MedhiPharmacology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Nilima KshirsagarClinical Pharmacology, Indian Council of Medical Research, New Delhi, India.
Deven ParmarDevelopment, Zydus Pharmaceuticals, Pennington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractThe manuscript summarizes the outcomes of a one-day conference by the South Asian College of American College of Clinical Pharmacology (SAC-ACCP) in July 2023, at Bhopal. The theme of the conference was "Advancing pediatric drug development in South Asia." SAC-ACCP organized this event in Bhopal to foster the discipline of clinical pharmacology and to motivate researchers and physicians in the in the central part of India. The conference featured presentations on regional approaches to pediatric drug development in Asia by pediatric scientific experts from the pharmaceutical industry, regulatory agencies, as well as independent consultancies. The speakers highlighted several important aspects of the evolving regulatory landscape in India and proposed numerous actionable steps in acceleration of pediatric drug development. This commentary provides insights from presentations and the panel discussion at this conference and also makes an attempt to connect to similar discussions that occurred at the SAC-ACCP drug development conference in 2017.

Indexed as

Drug DevelopmentPediatricsAsiaAsia, SouthernChildDrug IndustryHumansIndiaPharmacology, Clinical

Identifiers

PMID39250626
PMCPMC11483051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.